A new cause of renal thrombotic microangiopathy: Yttrium 90-DOTATOC internal radiotherapy
- 1 April 2001
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 37 (4) , 847-851
- https://doi.org/10.1016/s0272-6386(01)80135-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Yttrium-90-labelled somatostatin-analogue for cancer treatmentThe Lancet, 1998
- Anémie hémolytique microangiopathique associée à un sarcome utérin : rapport d'un cas. Revue de la littératureLa Revue de Médecine Interne, 1996
- Cisplatin-Associated hemolytic uremic syndromeCancer, 1994
- Thrombotic microangiopathy and renal failure as the initial manifestation of Hodgkin's diseaseNephrology Dialysis Transplantation, 1993
- Mitomycin-C Nephrotoxicity: A Clinico-Pathologic Study of 17 CasesAmerican Journal of Kidney Diseases, 1985
- Renal vascular lesions after chemotherapy with vinblastine, bleomycin, and cisplatinThe American Journal of Medicine, 1982
- Case Report Thrombotic thrombocytopenic purpura in a splenectomized patient with Hodgkin’s diseaseThe Lancet Healthy Longevity, 1980
- Microangiopathic Hemolytic Anemia in Metastatic CarcinomaAnnals of Internal Medicine, 1973
- Renal toxicity in man treated with mitomycin CCancer, 1971
- Thrombotic microangiopathy associated with squamous carcinoma.BMJ, 1969